The 36-Year Cancer Fight That Led To A Nobel ...

Brad Smith, President of Microsoft, discusses updated content from his book "Tools and Weapons: The Promise and the Peril of the Digital Age." Jennifer Surane, Finance Reporter for Bloomberg News, talks about her story, "Wall Street Limps Into Post-Labor Day Return Derailed by De ...  Show more

Phil Orlando, Chief Equity Market Strategist and Head of Client Portfolio Management at Federated Hermes, talks jobs and markets. Skylar Woodhouse, Reporter for Bloomberg News, discusses the aftermath of Hurricane Ida in New York City. Tom Bohn, President & CEO of the Association ...  Show more

Dr. Vinod Balachandran explains how he and his colleagues successfully treated pancreatic cancer with bespoke mRNA vaccines. Science journalist Charles Graeber says this could be cancer’s “penicillin moment.” This episode was produced by Avishay Artsy, edited by Matt Collette, fa ...  Show more

President Donald Trump weighed in on talks with US trade partners. Europe unveiled a push to attract researchers amid America’s changes to science policy. The Department of Homeland Security is offering undocumented migrants an incentive to self-deport. Researchers found a treatm ...  Show more

Episode 691: Neal and Toby unpack the latest chapter in the US-China trade war and how markets reacted to tensions renewed. Then, auto-parts supplier First Brands has its CEO step down after a financial implosion leaves billions of dollars of debt. Next, the Nobel prize is awarde ...  Show more

Episode 161: Neal and Toby break down the Sam Bankman-Fried and FTX fraud trial that is set to get underway today. How did we get here and what could be in store for the former king of crypto? Plus, the Nobel Prize was awarded to the creators of the mRNA vaccine and 'X' inks a de ...  Show more